BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 34597139)

  • 1. Pseudogene-mediated DNA demethylation leads to oncogene activation.
    Kwon J; Liu YV; Gao C; Bassal MA; Jones AI; Yang J; Chen Z; Li Y; Yang H; Chen L; Di Ruscio A; Tay Y; Chai L; Tenen DG
    Sci Adv; 2021 Oct; 7(40):eabg1695. PubMed ID: 34597139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA demethylation induces SALL4 gene re-expression in subgroups of hepatocellular carcinoma associated with Hepatitis B or C virus infection.
    Fan H; Cui Z; Zhang H; Mani SK; Diab A; Lefrancois L; Fares N; Merle P; Andrisani O
    Oncogene; 2017 Apr; 36(17):2435-2445. PubMed ID: 27797380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demethylation and Up-Regulation of an Oncogene after Hypomethylating Therapy.
    Liu YC; Kwon J; Fabiani E; Xiao Z; Liu YV; Follo MY; Liu J; Huang H; Gao C; Liu J; Falconi G; Valentini L; Gurnari C; Finelli C; Cocco L; Liu JH; Jones AI; Yang J; Yang H; Thoms JAI; Unnikrishnan A; Pimanda JE; Pan R; Bassal MA; Voso MT; Tenen DG; Chai L
    N Engl J Med; 2022 May; 386(21):1998-2010. PubMed ID: 35613022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudogene Annexin A2 Pseudogene 1 Contributes to Hepatocellular Carcinoma Progression by Modulating Its Parental Gene ANXA2 via miRNA-376a-3p.
    Ou H; Liu Q; Lin J; He W; Zhang W; Ma J; Wang W
    Dig Dis Sci; 2021 Nov; 66(11):3903-3915. PubMed ID: 33398718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a novel pseudogene pair-based prognostic signature for prediction of overall survival in patients with hepatocellular carcinoma.
    Du Y; Gao Y
    BMC Cancer; 2020 Sep; 20(1):887. PubMed ID: 32938429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of pseudogene HSPB1P1 and its potential roles in hepatocellular carcinoma.
    Tang D; Zhao X; Zhang L; Wang C
    J Cell Physiol; 2020 Oct; 235(10):6515-6527. PubMed ID: 31985034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Potential Diagnostic and Prognostic Pseudogenes in Hepatocellular Carcinoma Based on Pseudogene-miRNA-mRNA Competitive Network.
    Yan L; Yue C; Xu Y; Jiang X; Zhang L; Wu J
    Med Sci Monit; 2020 May; 26():e921895. PubMed ID: 32457285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MYC-regulated pseudogene HMGA1P6 promotes ovarian cancer malignancy via augmenting the oncogenic HMGA1/2.
    Tian X; Song J; Zhang X; Yan M; Wang S; Wang Y; Xu L; Zhao L; Wei JJ; Shao C; Kong B; Liu Z
    Cell Death Dis; 2020 Mar; 11(3):167. PubMed ID: 32127525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus X protein induces EpCAM expression via active DNA demethylation directed by RelA in complex with EZH2 and TET2.
    Fan H; Zhang H; Pascuzzi PE; Andrisani O
    Oncogene; 2016 Feb; 35(6):715-26. PubMed ID: 25893293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudogenes: pseudo-functional or key regulators in health and disease?
    Pink RC; Wicks K; Caley DP; Punch EK; Jacobs L; Carter DR
    RNA; 2011 May; 17(5):792-8. PubMed ID: 21398401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The transcription factor SALL4 regulates stemness of EpCAM-positive hepatocellular carcinoma.
    Zeng SS; Yamashita T; Kondo M; Nio K; Hayashi T; Hara Y; Nomura Y; Yoshida M; Hayashi T; Oishi N; Ikeda H; Honda M; Kaneko S
    J Hepatol; 2014 Jan; 60(1):127-34. PubMed ID: 24012616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pseudogene-derived long noncoding RNA SFTA1P is down-regulated and suppresses cell migration and invasion in lung adenocarcinoma.
    Zhang H; Xiong Y; Xia R; Wei C; Shi X; Nie F
    Tumour Biol; 2017 Feb; 39(2):1010428317691418. PubMed ID: 28231733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TET3 dioxygenase modulates gene conversion at the avian immunoglobulin variable region via demethylation of non-CpG sites in pseudogene templates.
    Takamura N; Seo H; Ohta K
    Genes Cells; 2021 Mar; 26(3):121-135. PubMed ID: 33421268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PseudoFuN: Deriving functional potentials of pseudogenes from integrative relationships with genes and microRNAs across 32 cancers.
    Johnson TS; Li S; Franz E; Huang Z; Dan Li S; Campbell MJ; Huang K; Zhang Y
    Gigascience; 2019 May; 8(5):. PubMed ID: 31029062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GENCODE pseudogenes.
    Frankish A; Harrow J
    Methods Mol Biol; 2014; 1167():129-55. PubMed ID: 24823776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The emerging role of pseudogene expressed non-coding RNAs in cellular functions.
    Groen JN; Capraro D; Morris KV
    Int J Biochem Cell Biol; 2014 Sep; 54():350-5. PubMed ID: 24842102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A FTH1 gene:pseudogene:microRNA network regulates tumorigenesis in prostate cancer.
    Chan JJ; Kwok ZH; Chew XH; Zhang B; Liu C; Soong TW; Yang H; Tay Y
    Nucleic Acids Res; 2018 Feb; 46(4):1998-2011. PubMed ID: 29240947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudogenes transcribed in breast invasive carcinoma show subtype-specific expression and ceRNA potential.
    Welch JD; Baran-Gale J; Perou CM; Sethupathy P; Prins JF
    BMC Genomics; 2015 Feb; 16(1):113. PubMed ID: 25765044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudogene PLGLA exerts anti-tumor effects on hepatocellular carcinoma through modulating miR-324-3p/GLYATL1 axis.
    Bao L; Li P; Zhao H; Chen L; Wang Y; Liang S; Liu J
    Dig Liver Dis; 2022 Jul; 54(7):918-926. PubMed ID: 34782279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR/Cas Technologies Applied to Pseudogenes.
    Vitiello M; Poliseno L
    Methods Mol Biol; 2021; 2324():265-284. PubMed ID: 34165721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.